Amphastar Director Sells 16,679 Shares for $441,800

Amphastar Pharmaceuticals, Inc. is a mid-cap biopharmaceutical company specializing in specialty and generic injectable and inhalation products. The company leverages a vertically integrated model, with in-house API production and a diverse product pipeline, to address critical needs in acute care and emergency medicine. Its strategic focus on both proprietary and generic products positions it to capture demand from institutional healthcare providers and respond to evolving market opportunities.Generates re ...